Compare Quanta Services Inc (PWR) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quanta Services Inc vs Viatris Inc — how do they compare? Quanta Services Inc trades at $628.79 (market cap $94.26B), while Viatris Inc trades at $16.5 (market cap $18.95B). The key difference: Quanta Services Inc is far larger — about 5× Viatris Inc's market cap, and Viatris Inc pays the higher dividend (2.91%). Which is the better fit depends on your goals.
| PWR | VTRS | |
|---|---|---|
Market Cap | $94.26B | $18.95B |
Sector | Industrials | Health |
52-Week High | $785.24 | $17.86 |
52-Week Low | $376.01 | $9.49 |
Enterprise Value | $100.36B | $31.07B |
Dividend Yield | 0.07% | 2.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PWR trades at $639.05, up 2.34% on the day, with a bullish technical signal and strong analyst support. The stock shows robust fundamentals, including a record $53 billion backlog and consecutive earnings beats, with Q2 2026 EPS of $4.24 surpassing estimates by 28%. Revenue growth accelerated to 41.1% year-over-year in Q2 2026, driven by infrastructure and data center demand.
The outlook remains positive given raised 2026 guidance and strategic positioning in AI-driven power projects, though high valuation multiples and investing cash outflows pose risks. Analyst consensus price target of $801.13 implies 25% upside, supported by 72% buy ratings. Execution on the massive backlog is critical for sustaining momentum.
Viatris (VTRS) trades at $16.61, down 1.6% on the day, with a bullish technical signal but mixed moving averages. The company reported Q2 2026 EPS of $0.69, beating estimates, and revenue growth of 5% year-over-year. Despite negative net income margins, strong cash flow generation supports dividends and buybacks. Recent news highlights pipeline progress and a higher 2026 outlook.
Outlook: Viatris shows operational strength with consistent earnings beats and cash flow, but high P/E and negative profitability pose risks. Investment opportunity lies in deleveraging and pipeline advancements, while headwinds include generic drug pricing pressure and regulatory uncertainty. Analyst sentiment is mixed with a hold-heavy consensus.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quanta Services Inc
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
